Global Ganja Report

Over the past two years, the Latin American cannabis industry has "emerged from the shadows" to command the attention of international firms and investors. Legal cannabis sales within the region are on track to reach $125 million in 2018—but that figure is expected to rise to $12.7 billion by 2028.

The woman behind the South American nation's new medical marijuana law may yet face prison time. Her crime? Providing the only medicine that worked for her ailing son.

In the working-class Lima district of Pueblo Libre, I make my way to an apartment complex and up to the flat of Ana Álvarez—the unlikely woman almost singly responsible for Peru’s groundbreaking new medical marijuana law.

In a bedroom, 18-year-old Anthony watches a noisy Spiderman movie, occasionally interrupting through the open door as I chat with his mom in the living room. Anthony suffers from tuberous sclerosis, a severe form of epilepsy, and was the voiceless central figure behind the events that led to a major reform of Peru’s drug laws in 2017.

Weeks after instating a new policy of not prosecuting for low-level marijuana violations, Manhattan District Attorney Cyrus Vance Jr addressed a meeting of New York cannabis industry investors and entrepreneurs, where he discussed his vision for fairer policing in the city—and his study calling for legalization to be explored at the state level.

The global cannabis industry is increasingly dependent on factories in China's industrial zones—and fears being impacted by Trump's trade war with Beijing. Chinese pharmaceutical firms meanwhile explore potential applications of cannabis. Yet possession of herbaceous cannabis can land you before a firing squad in China. Human rights groups express alarm about the furious pace of executions in the People's Republic—outstripping the rest of the world combined. And drug offenses—including pot possession—top the country's capital crimes.

A verdict against glyphosate producer Monsanto in a case brought by a cancer sufferer has brought world attention to the dangers of pesticides and herbicides. This is a question with implications already felt in the cannabis industry—both legal and illegal.

With the North American Free Trade Agreement under renegotiation, Mexico's former president and born-again cannabis advocate Vicente Fox is calling for the new treaty to include provisions for legal cross-border commerce in cannabis. But of course the federal governments of both the US and Mexico prohibit cannabis—despite growing demands for legalization both sides of the border.

What will ultimately be a multimedia extravaganza on the history, culture and politics of the cannabis plant is currently under production in New York City. The music for Cannabis! A Theatrical Concert was just unveiled for New York audiences in a special performance at a nightspot on Manhattan's Lower East Side.

Having just undertaken a "critical study" of CBD, the non-psychoactive cannabinoid held to have multifarious medicinal applications, the World Health Organization is now opening such a study on THC. Stigmatized due to its psychoactive properties and currently in the shadow of the suddenly sexy CBD, tetrahydrocannabinol shows its own potential for application by the medical industry.